Ankylosing spondylitis is a common autoimmune disease that cannot be completely cured. But with standardized treatment, the disease can be controlled.
Ankylosing spondylitis is a chronic inflammatory disease affecting the spine, sacroiliac joints and other joints, and belongs to the category of rheumatic immune diseases, which cannot be completely cured at present. The onset of the disease is mainly related to genetic factors, infectious factors and environmental factors.
Early symptoms include pain or discomfort in the buttocks, groin and lower back, and as the disease progresses, inflammatory low back pain, peripheral arthritis, tendonitis and other symptoms may appear.
Patients can follow the doctor’s instructions to apply non-steroidal anti-inflammatory drugs such as celecoxib and anti-rheumatic drugs such as sulfasalazine and interleukin-17 monoclonal antibody to control the condition, promote the disappearance of inflammation, and alleviate the patient’s pain.
During the treatment period, patients need to pay attention to avoid excessive weight bearing, not long-term sedentary and standing, moderate exercise. It is recommended that patients with ankylosing spondylitis go to the rheumatology and immunology department and orthopedics department of regular hospitals for detailed consultation and follow the doctor’s instructions.